CO150 Examining the Relationship between Prolonged QTc Risk Score and in-Hospital Mortality

Autor: MS Tan, CW Heise, T Gallo, JE Tisdale, RL Woosley, CC Antonescu, S Gephart, DC Malone

Publikováno v: Value in Health. 25:S332

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::bb77953da981ea66cd0b319876697ebb
https://doi.org/10.1016/j.jval.2022.04.244

Clinical decision support to reduce unnecessary diagnostic testing for heparin-induced thrombocytopenia.

Autor: Gallo T; Division of Clinical Data Analytics and Decision Support, University of Arizona College of Medicine - Phoenix, Phoenix, Arizona, USA.; Department of Pharmacy Practice and Science, University of Arizona College of Pharmacy, Phoenix, Arizona, USA., Curry SC; Division of Clinical Data Analytics and Decision Support, University of Arizona College of Medicine - Phoenix, Phoenix, Arizona, USA.; Department of Medical Toxicology, Banner - University Medical Center Phoenix, Phoenix, Arizona, USA., Heise CW; Division of Clinical Data Analytics and Decision Support, University of Arizona College of Medicine - Phoenix, Phoenix, Arizona, USA.; Department of Medical Toxicology, Banner - University Medical Center Phoenix, Phoenix, Arizona, USA., Antonescu CC; Banner Health, Greeley, Colorado, USA., Raschke RA; Division of Clinical Data Analytics and Decision Support, University of Arizona College of Medicine - Phoenix, Phoenix, Arizona, USA.

Publikováno v: British journal of haematology [Br J Haematol] 2023 Sep; Vol. 202 (5), pp. 1011-1017. Date of Electronic Publication: 2023 Jun 04.

Relationship between a risk score for QT interval prolongation and mortality across rural and urban inpatient facilities.

Autor: Tan MS; Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA., Heise CW; Division of Clinical Data Analytics and Decision Support, University of Arizona College of Medicine - Phoenix, Phoenix, AZ, USA; Department of Medical Toxicology, Banner - University Medical Center Phoenix, Phoenix, AZ, USA., Gallo T; Division of Clinical Data Analytics and Decision Support, University of Arizona College of Medicine - Phoenix, Phoenix, AZ, USA; Department of Pharmacy Practice and Science, University of Arizona College of Pharmacy, Phoenix, AZ, USA., Tisdale JE; Department of Pharmacy Practice, College of Pharmacy, Purdue University, Indianapolis, IN, USA; Division of Clinical Pharmacology, School of Medicine, Indiana University, Indianapolis, IN, USA., Woosley RL; Division of Clinical Data Analytics and Decision Support, University of Arizona College of Medicine - Phoenix, Phoenix, AZ, USA; Arizona Center for Education and Research on Therapeutics (AZCERT), Tucson, AZ, USA., Antonescu CC; BannerHealth, Greeley, CO, USA., Gephart SM; Community and Health Systems Science Division, College of Nursing, University of Arizona, Tucson, AZ, USA., Malone DC; Department of Pharmacotherapy, College of Pharmacy, University of Utah, Salt Lake City, UT, USA. Electronic address: Dan.Malone@utah.edu.

Publikováno v: Journal of electrocardiology [J Electrocardiol] 2023 Mar-Apr; Vol. 77, pp. 4-9. Date of Electronic Publication: 2022 Dec 09.

COVID-19 Time of Intubation Mortality Evaluation (C-TIME): A system for predicting mortality of patients with COVID-19 pneumonia at the time they require mechanical ventilation.

Autor: Raschke RA; The Division of Clinical Data Analytics and Decision Support, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, United States of America.; University of Arizona College of Medicine-Phoenix, Phoenix, AZ, United States of America., Rangan P; University of Arizona College of Medicine-Phoenix, Phoenix, AZ, United States of America.; Department of Internal Medicine, Banner-University Medical Center Phoenix, Phoenix, AZ, United States of America., Agarwal S; University of Arizona College of Medicine-Phoenix, Phoenix, AZ, United States of America.; Department of Internal Medicine, Banner-University Medical Center Phoenix, Phoenix, AZ, United States of America., Uppalapu S; University of Arizona College of Medicine-Phoenix, Phoenix, AZ, United States of America.; Department of Internal Medicine, Banner-University Medical Center Phoenix, Phoenix, AZ, United States of America., Sher N; University of Arizona College of Medicine-Phoenix, Phoenix, AZ, United States of America., Curry SC; The Division of Clinical Data Analytics and Decision Support, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, United States of America.; Department of Medical Toxicology, Banner-University Medical Center Phoenix, Phoenix, AZ, United States of America., Heise CW; The Division of Clinical Data Analytics and Decision Support, University of Arizona College of Medicine-Phoenix, Phoenix, AZ, United States of America.; Department of Medical Toxicology, Banner-University Medical Center Phoenix, Phoenix, AZ, United States of America.

Publikováno v: PloS one [PLoS One] 2022 Jul 06; Vol. 17 (7), pp. e0270193. Date of Electronic Publication: 2022 Jul 06 (Print Publication: 2022).

Evaluation of the Veterans Affairs Pharmacogenomic Testing for Veterans (PHASER) clinical program at initial test sites.

Autor: Dong OM; Durham VA Health Care System, Durham, NC 27705, USA.; Department of Medicine, Duke Center for Applied Genomics & Precision Medicine, Duke University School of Medicine, Durham, NC 27708, USA., Roberts MC; Division of Pharmaceutical Outcomes & Policy, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Wu RR; Durham VA Health Care System, Durham, NC 27705, USA.; Department of Medicine, Duke Center for Applied Genomics & Precision Medicine, Duke University School of Medicine, Durham, NC 27708, USA., Voils CI; William S Middleton Memorial Veterans Hospital, Madison, WI 53705, USA.; Department of Surgery, University of Wisconsin School of Medicine & Public Health, Madison, WI 53792, USA., Sperber N; Duke Department of Population Health Sciences, Duke University School of Medicine, Durham, NC 27701, USA., Gavin KL; William S Middleton Memorial Veterans Hospital, Madison, WI 53705, USA.; Department of Surgery, University of Wisconsin School of Medicine & Public Health, Madison, WI 53792, USA., Bates J; Durham VA Health Care System, Durham, NC 27705, USA.; Division of Practice Advancement & Clinical Education, UNC Eshelman School of Pharmacy, University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA., Chanfreau-Coffinier C; VA Informatics & Computing Infrastructure (VINCI), Salt Lake City VA Health Care System, Salt Lake City, UT 84148, USA., Naglich M; Institute for Medical Research, Durham VA Medical Center, Durham, NC 27705, USA., Kelley MJ; Durham VA Health Care System, Durham, NC 27705, USA.; Department of Medicine, Duke University Medical Center, Durham, NC 27708, USA.; National Oncology Program Office, Office of Specialty Care, Department of Veterans Affairs, Durham, NC 27705, USA., Vassy JL; VA Boston Healthcare System, Boston, MA 02130, USA.; Harvard Medical School, Boston, MA 02115, USA., Sriram P; North Florida/South Georgia Veterans Health System, Gainesville, FL 32608, USA., Heise CW; Phoenix VA Health Care System, Phoenix, AZ 85012, USA.; The University of Arizona College of Medicine - Phoenix, Phoenix, AZ 85004, USA., Rivas S; Phoenix VA Health Care System, Phoenix, AZ 85012, USA.; The University of Arizona College of Medicine - Phoenix, Phoenix, AZ 85004, USA., Ribeiro M; Atlanta VA Medical Center, Atlanta, GA 30033, USA.; Department of Hematology & Medical Oncology, Emory University School of Medicine, Atlanta, GA 30322, USA., Chapman JG; Institute for Medical Research, Durham VA Medical Center, Durham, NC 27705, USA., Voora D; Durham VA Health Care System, Durham, NC 27705, USA.; Department of Medicine, Duke Center for Applied Genomics & Precision Medicine, Duke University School of Medicine, Durham, NC 27708, USA.

Publikováno v: Pharmacogenomics [Pharmacogenomics] 2021 Nov; Vol. 22 (17), pp. 1121-1133. Date of Electronic Publication: 2021 Oct 27.